Literature DB >> 2052149

Muscarinic cholinergic receptors in the rat caudate-putamen and olfactory tubercle belong predominantly to the m4 class: in situ hybridization and receptor autoradiography evidence.

M T Vilaró1, K H Wiederhold, J M Palacios, G Mengod.   

Abstract

In order to establish the nature of the muscarinic cholinergic receptors present in the rat caudate-putamen and olfactory tubercle, we have combined in situ hybridization histochemistry with oligonucleotide probes and receptor autoradiography with N-[3H]methyl scopolamine and several subtype-selective antagonists: hexahydro-sila-difenidol, p-fluoro-hexahydro-sila-difenidol, 4-diphenyl-acetoxy-N-methylpiperidine methbromide, AF-DX 116, pirenzepine and methoctramine. In both brain regions, transcripts for the m4 muscarinic receptor subtype were the most abundant, followed by transcripts for the m1 subtype. m2 and m3 transcripts were much less abundant, whereas m5 mRNA was not detected under the present conditions. The binding profiles obtained in these areas were clearly distinct from those obtained in the CA1 layer of the hippocampus and in the pontine nuclei, regions enriched in M1 and M2 sites, respectively. In contrast, they were good agreement with the characteristics of atypical muscarinic receptors present in cell lines such as NG108-15, which contains mRNA for the m4 subtype, and PC12. The profiles displayed by some of the compounds used in the present study for cloned m4 receptors expressed in mammalian cells also agree with our results in rat caudate-putamen and olfactory tubercule. Taken together, these facts support the existence, in rat caudate-putamen and olfactory tubercle, of a major population of muscarinic cholinergic receptors belonging to the M4 type.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2052149     DOI: 10.1016/0306-4522(91)90181-m

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  9 in total

Review 1.  Autoradiographical and immunohistochemical analysis of receptor localization in the central nervous system.

Authors:  J G Chabot; S Kar; R Quirion
Journal:  Histochem J       Date:  1996-11

Review 2.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

3.  Acetylcholine from the mesopontine tegmental nuclei differentially affects methamphetamine induced locomotor activity and neurotransmitter levels in the mesolimbic pathway.

Authors:  Lauren K Dobbs; Gregory P Mark
Journal:  Behav Brain Res       Date:  2011-09-17       Impact factor: 3.332

Review 4.  The cholinergic system and neostriatal memory functions.

Authors:  Robbert Havekes; Ted Abel; Eddy A Van der Zee
Journal:  Behav Brain Res       Date:  2010-12-01       Impact factor: 3.332

5.  Muscarinic receptor/G-protein coupling is reduced in the dorsomedial striatum of cognitively impaired aged rats.

Authors:  Erasmo Nieves-Martinez; Kathryn Haynes; Steven R Childers; William E Sonntag; Michelle M Nicolle
Journal:  Behav Brain Res       Date:  2011-11-07       Impact factor: 3.332

6.  Neuronal expression of zinc finger transcription factor REST/NRSF/XBR gene.

Authors:  K Palm; N Belluardo; M Metsis; T Timmusk
Journal:  J Neurosci       Date:  1998-02-15       Impact factor: 6.167

7.  Kinetics of the functional loss of different muscarinic receptor isoforms in Xenopus oocytes.

Authors:  N Matus-Leibovitch; G Mengod; Y Oron
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

Review 8.  Regulation of Glutamatergic Activity via Bidirectional Activation of Two Select Receptors as a Novel Approach in Antipsychotic Drug Discovery.

Authors:  Paulina Cieślik; Joanna M Wierońska
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

Review 9.  Neurochemical organization of the ventral striatum's olfactory tubercle.

Authors:  Hillary L Cansler; Katherine N Wright; Lucas A Stetzik; Daniel W Wesson
Journal:  J Neurochem       Date:  2020-01-07       Impact factor: 5.372

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.